LKIM
Lawson Kroeker Investment Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.66M | Sell |
50,473
-5,518
| -10% | -$837K | 1.42% | 24 |
|
|
2025
Q1 | $8.43M | Buy |
55,991
+954
| +2% | +$144K | 1.56% | 22 |
|
|
2024
Q4 | $10.2M | Sell |
55,037
-1,498
| -3% | -$277K | 1.91% | 18 |
|
|
2024
Q3 | $11.1M | Buy |
56,535
+1,077
| +2% | +$212K | 2.03% | 16 |
|
|
2024
Q2 | $11.5M | Buy |
55,458
+300
| +0.5% | +$62K | 2.21% | 14 |
|
|
2024
Q1 | $14.9M | Sell |
55,158
-163
| -0.3% | -$44.2K | 2.83% | 10 |
|
|
2023
Q4 | $13.1M | Sell |
55,321
-13
| -0% | -$3.07K | 2.68% | 12 |
|
|
2023
Q3 | $10.8M | Buy |
55,334
+172
| +0.3% | +$33.7K | 2.39% | 13 |
|
|
2023
Q2 | $11.6M | Buy |
55,162
+223
| +0.4% | +$46.9K | 2.78% | 11 |
|
|
2023
Q1 | $11.1M | Buy |
+54,939
| New | +$11.1M | 2.49% | 10 |
|